Comac Medical has conducted an assessment in IMP³rove – an instrument provided by the European Commission for measurement of the innovation potential of the company, which ranked the company among the growth champions in Europe.
IMP³rove assessment
October 19, 2015
Share:
News
Abstract: In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120...
Landmark Changes Position Company for Continued Growth and Innovation Sofia, December 6, 2023 – Comac Medical, a leading...
The Bulgarian Drug Agency has announced reduced time periods for consideration of clinical trials on medicinal products for...